1.

1. BOH Agenda

2.

2. BOH Correspondence

Documents:
  1. LINCS_Monkeypox_5_202220222005.pdf
  2. LINCS_Updated Monkeypox Guidance_6_202220221706.pdf
  3. Monkeypox contact monitoring June 23 202220222306.pdf
  4. Monkeypox Investigation Form_Updated20222505.pdf
  5. NJ PHEL-Monkeypox Guidance Document Updated 6-16-2220221706.pdf
  6. Public Health Recall _ iCast Covered Stent by Atrium Medical_ Class I Recall.pdf
  7. Public Health Recall _ Ukoniq (umbralisib)_ Drug Safety Communication - FDA Approval of Lymphoma Medicine is Withdrawn Due to Safety Concerns.pdf
  8. RWI_LINCS_202220222305.pdf
  9. Updated booster recommendations and implications.pdf
  10. Vector-borne Report_Week 2220220906.pdf
  11. Vector-borne Report_Week 2320221606.pdf
  12. Vector-borne Report_Week 2420222306.pdf
  13. ASRP 2022 Call for Applications Information20220106.pdf
  14. CDC HAN COVID19 Rebound20222405.pdf
  15. CDC HAN Monkeypox_5_202220222005.pdf
  16. CDC HAN Monkeypox_6_202220221706.pdf
  17. COVID 19 Report_Week_2020222605.pdf
  18. COVID 19 Report_Week_2120220206.pdf
  19. COVID 19 Report_Week_2220220906.pdf
  20. COVID-19 Variant Report_surveillance data_05.23.2220222305.pdf
  21. COVID-19 Variant Report_surveillance data_05.31.2220223105.pdf
  22. COVID-19 Variant Report_surveillance data_06.6.2220220606.pdf
  23. COVID-19 Variant Report_surveillance data_06.13.2220221306.pdf
  24. COVID-19 Variant Report_surveillance data_06.20.2220222006.pdf
  25. COVID-19 Weekly Surveillance Report 6_17_2220221706.pdf
  26. Influenza and Respiratory Illness Surveillance Report_MMWR Week 2020222505.pdf
  27. Influenza and Respiratory Illness Surveillance Report_MMWR Week 2120220106.pdf
  28. Influenza and Respiratory Illness Surveillance Report_MMWR Week 2220220806.pdf
  29. Influenza and Respiratory Illness Surveillance Report_MMWR Week 2320221506.pdf
  30. Influenza and Respiratory Illness Surveillance Report_MMWR Week 2420222206.pdf
  31. LINCS_Clinical Manifestations of Monkeypox_6_202220221306.pdf
  32. LINCS_Monkeypox Update_5_25_202220222505.pdf
  33. 2022-05-31_Access_Request_Letter.pdf
4.

4. Items of Discussion